Matches in Wikidata for { <http://www.wikidata.org/entity/Q37762800> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q37762800 description "article científic" @default.
- Q37762800 description "article scientifique" @default.
- Q37762800 description "articolo scientifico" @default.
- Q37762800 description "artigo científico" @default.
- Q37762800 description "artículu científicu espublizáu en 2010" @default.
- Q37762800 description "bilimsel makale" @default.
- Q37762800 description "scientific article published on January 2010" @default.
- Q37762800 description "vedecký článok" @default.
- Q37762800 description "vetenskaplig artikel" @default.
- Q37762800 description "videnskabelig artikel" @default.
- Q37762800 description "vědecký článek" @default.
- Q37762800 description "wetenschappelijk artikel" @default.
- Q37762800 description "wissenschaftlicher Artikel" @default.
- Q37762800 description "наукова стаття, опублікована в січні 2010" @default.
- Q37762800 description "научни чланак" @default.
- Q37762800 description "գիտական հոդված հրատարակված 2010 թվականի հունվարին" @default.
- Q37762800 description "مقالة علمية نشرت في يناير 2010" @default.
- Q37762800 name "Use of calcium channel blockers in cardiovascular risk reduction: issues in Latin America" @default.
- Q37762800 name "Use of calcium channel blockers in cardiovascular risk reduction: issues in Latin America" @default.
- Q37762800 name "Use of calcium channel blockers in cardiovascular risk reduction: issues in Latin America" @default.
- Q37762800 type Item @default.
- Q37762800 label "Use of calcium channel blockers in cardiovascular risk reduction: issues in Latin America" @default.
- Q37762800 label "Use of calcium channel blockers in cardiovascular risk reduction: issues in Latin America" @default.
- Q37762800 label "Use of calcium channel blockers in cardiovascular risk reduction: issues in Latin America" @default.
- Q37762800 prefLabel "Use of calcium channel blockers in cardiovascular risk reduction: issues in Latin America" @default.
- Q37762800 prefLabel "Use of calcium channel blockers in cardiovascular risk reduction: issues in Latin America" @default.
- Q37762800 prefLabel "Use of calcium channel blockers in cardiovascular risk reduction: issues in Latin America" @default.
- Q37762800 P1433 Q37762800-6025DA12-E719-48EE-B980-13FE37DF2D23 @default.
- Q37762800 P1476 Q37762800-1280F7F5-4A7F-47FA-B679-DB9F971B8C3C @default.
- Q37762800 P2093 Q37762800-439357A5-9B20-448B-BE87-A2565E09A3E3 @default.
- Q37762800 P2093 Q37762800-89875DE5-3299-4696-95C5-159591E3EAF9 @default.
- Q37762800 P2093 Q37762800-90CF4621-86BB-46D4-AA4F-BFE42F29C04C @default.
- Q37762800 P2093 Q37762800-CA0D4A42-5D32-4A98-892B-AE2D32C8C92C @default.
- Q37762800 P2860 Q37762800-6B9BDEC1-72DC-4FB4-A322-FDCFF260F614 @default.
- Q37762800 P2860 Q37762800-888BB3C8-8207-4C2C-90E6-2676DEDA0BAD @default.
- Q37762800 P2860 Q37762800-A99D3B51-FA5D-439F-B995-AB5D7619D485 @default.
- Q37762800 P2860 Q37762800-B3BE6C6F-B6AB-4F63-8FF4-734E0ED500A9 @default.
- Q37762800 P2860 Q37762800-B5096E92-8E42-4A8F-954C-FA97B11B5BD4 @default.
- Q37762800 P2888 Q37762800-222691D9-6F05-4241-AC80-36252B070518 @default.
- Q37762800 P304 Q37762800-35FB5129-C3DF-4124-B070-56CF9791D04A @default.
- Q37762800 P31 Q37762800-B72CB9CB-40C1-4C17-B033-CA7455F45432 @default.
- Q37762800 P31 Q37762800-f6aca7cd-f8f4-47a4-b7a0-84e7b8d95a5c @default.
- Q37762800 P356 Q37762800-C95A748B-D02F-49DF-8249-88B43ACEC7BD @default.
- Q37762800 P433 Q37762800-C8DD8E7A-D1EE-48C7-A195-4FA97796B180 @default.
- Q37762800 P478 Q37762800-6CAD1437-E1BE-46D4-A7FB-0C5213B71F33 @default.
- Q37762800 P577 Q37762800-BA4F1A5D-5240-44B9-B0CF-175B4C41A639 @default.
- Q37762800 P5875 Q37762800-62B50129-2406-4A31-A08B-C68BA4C2B13D @default.
- Q37762800 P6179 Q37762800-98AF7E57-14B7-4092-B598-46F291B09C37 @default.
- Q37762800 P698 Q37762800-4AE6DA0C-41DB-498A-92D0-F6DD0AD2EED1 @default.
- Q37762800 P356 11536120-000000000-00000 @default.
- Q37762800 P698 20524716 @default.
- Q37762800 P1433 Q2555367 @default.
- Q37762800 P1476 "Use of calcium channel blockers in cardiovascular risk reduction: issues in Latin America" @default.
- Q37762800 P2093 "Julio Acosta" @default.
- Q37762800 P2093 "Luis Alcocer" @default.
- Q37762800 P2093 "Mario Bendersky" @default.
- Q37762800 P2093 "Miguel Urina-Triana" @default.
- Q37762800 P2860 Q22306385 @default.
- Q37762800 P2860 Q32185831 @default.
- Q37762800 P2860 Q43641695 @default.
- Q37762800 P2860 Q43645315 @default.
- Q37762800 P2860 Q47405955 @default.
- Q37762800 P2888 11536120-000000000-00000 @default.
- Q37762800 P304 "143-154" @default.
- Q37762800 P31 Q13442814 @default.
- Q37762800 P31 Q7318358 @default.
- Q37762800 P356 "10.2165/11536120-000000000-00000" @default.
- Q37762800 P433 "3" @default.
- Q37762800 P478 "10" @default.
- Q37762800 P577 "2010-01-01T00:00:00Z" @default.
- Q37762800 P5875 "44650701" @default.
- Q37762800 P6179 "1001790903" @default.
- Q37762800 P698 "20524716" @default.